What Is Treatment-Resistant Depression?
After being found to have a depression disorder, you expect treatments to help control symptoms like hopelessness, anxiety, and low energy. However, what do you do if customary antidepressants don’t offer relief or make things more unpleasant? If you have tried at least two treatments in the past and still grapple with depression, you could have Treatment-Resistant Depression (TRD). Find more details about this condition and see if you or someone you love could have Treatment-Resistant Depression.
How Are Patients Diagnosed With Treatment-Resistant Depression In Middlesex?
Treatment-resistant depression describes patients with major depressive disorder (MDD) who have not been helped by two or more oral antidepressants taken as prescribed and for the full duration. Although you could notice temporary mood improvements, they are most often followed by additional symptoms. You might even find that your bouts of depression are more prolonged and intense.
If antidepressants don’t work for you, you’re not alone. In one study’s findings, between 29% and 46% of participants didn’t get extended relief from oral antidepressants.
What Are TRD Symptoms?
TRD is form of Major Depressive Disorder. Therefore, the symptoms of treatment-resistant depression are familiar, but you are unable to feel relief from traditional antidepressants. These symptoms can include:
- Continuing sadness or hopelessness
- No interest or enjoyment from activities
- Fluctuations in weight or appetite
- Sleep issues like lethargy or insomnia
- Detrimental emotions about oneself.
- Problems paying attention
- Phantom joint pain, back pain, or headaches
- Self-harm
- Repeated thoughts of death or suicide
It's essential to understand that the consistency and acuteness of these symptoms, regardless of treatment, make TRD distinctive from other instances of depression. Also, managing TRD typically calls for a more involved form of depression treatment near Middlesex, possibly including a blend of medicine and psychotherapy.
SPRAVATO Approved For Treatment-Resistant Depression
SPRAVATO is the first FDA-approved nasal spray to treat people 18 or older with treatment-resistant depression. Esketamine is the active chemical ingredient and is believed to mitigate symptoms by affecting certain brain pathways. In a clinical trial, individuals who were administered Spravato and an oral antidepressant had a more effective reduction in depressive symptoms after four weeks than individuals who were provided a placebo and an antidepressant.
SPRAVATO is administered under the supervision of medical professionals at a facility authorized by the Risk Evaluation and Mitigation Strategy (REMS) program. A thorough examination of your medical history is required in advance of treatment. Potentially serious side effects may result, such as feelings of detachment and sedation, and patients have to be watched for two hours after treatment.
Get Help For Treatment-resistant Depression In Middlesex At The Counseling Center at Middlesex
Treatment-resistant depression may bring on a new level of anxiety with thoughts that your situation may not get better. However, a new approach to medicine, therapy, and professional support will help you work through TRD. The Counseling Center at Middlesex is standing by to help. We offer a number of mental health services for treatment-resistant depression and are a certified SPRAVATO treatment center. Get help today by contacting us at 732-629-9510 or filling out the simple form on this page.